Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharyngeal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05145660
What this trial is testing

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Who this might be right for
Nasopharyngeal Carcinoma
Yi Junlin 414
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Not applicableUnknownNCT06024980
What this trial is testing

Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy

Who this might be right for
Laryngeal CancerDysphagia
Guangdong Provincial People's Hospital 50
Testing effectiveness (Phase 2)UnknownNCT04143984
What this trial is testing

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 146
Post-approval studies (Phase 4)Study completedNCT00666978
What this trial is testing

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Lisa Sanderson Cox, PhD 540
Very early researchNot Yet RecruitingNCT06370026
What this trial is testing

KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 12
Not applicableLooking for participantsNCT07326358
What this trial is testing

AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study

Who this might be right for
Nasopharyngeal NeoplasmsLaryngeal Disease
Ruijin Hospital 500
Early research (Phase 1)Not Yet RecruitingNCT07741643
What this trial is testing

Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCC,Larynx, Pharynx and Oral CavitySquamous Cell CarcinomaHead and Neck Cancer+1 more
Vanderbilt-Ingram Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05193617
What this trial is testing

Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 104
Early research (Phase 1)Study completedNCT00978081
What this trial is testing

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Who this might be right for
Head and Neck CancerPrecancerous Condition
Abramson Cancer Center at Penn Medicine 35
Early research (Phase 1)UnknownNCT05415098
What this trial is testing

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Nasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more
Ascentage Pharma Group Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT05799144
What this trial is testing

PBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Who this might be right for
Metastatic Oropharyngeal CarcinomaRecurrent Oropharyngeal Carcinoma
Michael K. Gibson 54
Not applicableLooking for participantsNCT04425265
What this trial is testing

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma

Who this might be right for
SurgeryRecurrent Nasopharyngeal Carcinoma
Sun Yat-sen University 500
Not applicableNot Yet RecruitingNCT07622407
What this trial is testing

Maximizing Quality of Life After Cancer Through Rehabilitation

Who this might be right for
Head and Neck CancerHearing LossTinnitus+1 more
VA Office of Research and Development 74
Large-scale testing (Phase 3)Ended earlyNCT00537199
What this trial is testing

OraTest in Combination With Visual Examination and Visual Examination Alone

Who this might be right for
Head And Neck CancerOropharynx Cancer
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT03755921
What this trial is testing

Brief and Intensive Therapy for Dysphagia in Patients With Head and Neck Cancer

Who this might be right for
Deglutition DisordersDysphagiaHead and Neck Cancer+1 more
Federal University of Health Science of Porto Alegre 20
Testing effectiveness (Phase 2)Looking for participantsNCT06323460
What this trial is testing

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Oropharyngeal Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)UnknownNCT03290820
What this trial is testing

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 184
Testing effectiveness (Phase 2)Study completedNCT01392235
What this trial is testing

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Recurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 58
Next Page